NIAID

NIAID

First New HIV Vaccine Efficacy Study in Seven Years Underway

Health International
The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. ...
Read more 0

HIV-Infected Men at Increased Risk for Heart Disease, Study

Top News Health
The buildup of soft plaque in arteries that nourish the heart is more common and extensive in HIV-infected men than HIV-uninfected men, a new study shows. ...
Read more 0

Genetic Modification of Cells Proves Generally Safe as HIV Treatment

Top News Health
Scientists Wednesday reported initial results from humans on the safety and tolerability of a novel strategy to curb HIV disease by removing key cells. ...
Read more 0

NIAID Awards 14 Grants for HIV Vaccine Research

NIAID Awards 14 Grants for HIV Vaccine Research
The grants were awarded under the Innovation for HIV Vaccine Discovery initiative, which is expected to receive up to $34.8 million over the next four years. ...
Read more 0

HIV Superinfection in Uganda More Common Than Originally Thought, New Study

HIV Superinfection in Uganda More Common Than Originally Thought, New Study
HIV superinfection in Uganda may be more common than previously thought, study finds. ...
Read more 0